Abbott Laboratories buy Stifel Nicolaus
Start price
17.04.25
/
50%
€115.06
Target price
17.04.26
€127.60
Performance (%)
-14.44%
Price
27.02.26
€98.44
Summary
This prediction is currently active. The price of Abbott Laboratories has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.44%. This prediction currently runs until 17.04.26. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Abbott Laboratories | 3.393% | 3.393% |
| iShares Core DAX® | -0,38 % | 1,09 % |
| iShares Nasdaq 100 | -0,41 % | -1,97 % |
| iShares Nikkei 225® | 1,84 % | 10,26 % |
| iShares S&P 500 | -0,71 % | 0,44 % |
Comments by Stifel_Nicolaus for this prediction
In the thread Discuss Abbott Laboratories
Abbott Laboratories (NYSE: ABT) had its price target raised by analysts at Stifel Nicolaus from $135.00 to $145.00. They now have a "buy" rating on the stock.
Ratings data for ABT provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for Abbott Laboratories
Abbott Laboratories
Start price
Target price
Perf. (%)
€113.50
23.01.25
23.01.25
€129.61
23.01.26
23.01.26
-19.76%
24.01.26
24.01.26
